Merck & Co., Inc. (MRK)
147.74
+0.79
(+0.54%)
USD |
NYSE |
Nov 13, 16:00
147.75
+0.01
(+0.01%)
After-Hours: 19:59
Merck Total Assets (Quarterly) : 132.77B for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 132.77B |
| June 30, 2026 | 129.80B |
| March 31, 2026 | 128.68B |
| December 31, 2025 | 136.87B |
| September 30, 2025 | 129.55B |
| June 30, 2025 | 117.52B |
| March 31, 2025 | 115.12B |
| December 31, 2024 | 117.11B |
| September 30, 2024 | 117.53B |
| June 30, 2024 | 112.63B |
| March 31, 2024 | 105.85B |
| December 31, 2023 | 106.68B |
| September 30, 2023 | 106.73B |
| June 30, 2023 | 104.47B |
| March 31, 2023 | 107.80B |
| December 31, 2022 | 109.16B |
| September 30, 2022 | 107.08B |
| June 30, 2022 | 107.10B |
| March 31, 2022 | 106.67B |
| December 31, 2021 | 105.69B |
| September 30, 2021 | 93.49B |
| June 30, 2021 | 90.69B |
| March 31, 2021 | 90.85B |
| December 31, 2020 | 91.59B |
| September 30, 2020 | 89.80B |
| Date | Value |
|---|---|
| June 30, 2020 | 90.62B |
| March 31, 2020 | 84.91B |
| December 31, 2019 | 84.40B |
| September 30, 2019 | 83.33B |
| June 30, 2019 | 83.96B |
| March 31, 2019 | 82.35B |
| December 31, 2018 | 82.64B |
| September 30, 2018 | 85.13B |
| June 30, 2018 | 85.04B |
| March 31, 2018 | 86.04B |
| December 31, 2017 | 87.87B |
| September 30, 2017 | 91.68B |
| June 30, 2017 | 92.80B |
| March 31, 2017 | 96.56B |
| December 31, 2016 | 95.38B |
| September 30, 2016 | 98.34B |
| June 30, 2016 | 96.48B |
| March 31, 2016 | 98.76B |
| December 31, 2015 | 101.78B |
| September 30, 2015 | 101.23B |
| June 30, 2015 | 102.58B |
| March 31, 2015 | 108.34B |
| December 31, 2014 | 98.34B |
| September 30, 2014 | 101.81B |
| June 30, 2014 | 97.86B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Johnson & Johnson | 197.42B |
| Eli Lilly & Co. | 148.07B |
| Pfizer Inc. | 204.54B |
| Bristol Myers Squibb Co. | 88.77B |
| Abbott Laboratories | 108.25B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 87.83B |
| Shareholders Equity (Quarterly) | 44.89B |
| Debt to Equity Ratio | 1.198 |
| Current Ratio | 1.352 |
| Net Debt Paydown Yield | -1.03% |